Regardless of the information from Dew's source, which I will try to inquire about after Teva will report 3Q10 next week, I think the answer to the question - can Teva's ANDA for generic Lovenox pass the high bar placed by Momenta, is - no. And if it takes few more years, as I suspect, Teva might withdrawal.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.